These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3162377)

  • 21. Anti-interleukin 6 receptor antibody inhibits murine AA-amyloidosis.
    Mihara M; Shiina M; Nishimoto N; Yoshizaki K; Kishimoto T; Akamatsu K
    J Rheumatol; 2004 Jun; 31(6):1132-8. PubMed ID: 15170926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amyloid-enhancing factor (AEF) in the pathogenesis of AA-amyloidosis in the hamster.
    Hol PR; Snel FW; Niewold TA; Gruys E
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 52(3):273-81. PubMed ID: 2879382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inactivation of amyloid-enhancing factor (AEF): study on experimental murine AA amyloidosis.
    Omoto M; Yokota T; Cui D; Hoshii Y; Kawano H; Gondo T; Ishihara T; Kanda T
    Med Mol Morphol; 2007 Jun; 40(2):88-94. PubMed ID: 17572844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amyloid enhancing factor (AEF) in the aging mouse.
    Yokota T; Ishihara T; Kawano H; Takahashi M; Fujinaga Y; Uchino F
    Virchows Arch A Pathol Anat Histopathol; 1989; 414(6):511-4. PubMed ID: 2499108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amyloid enhancing factor (AEF). Isolation and biochemical and pathological characteristics.
    Yokota T; Takahashi M; Ishihara T; Yamashita Y; Gondo T; Kawamura S; Hoshii Y; Koga M; Iwata T; Uchino F
    Acta Pathol Jpn; 1991 Nov; 41(11):798-805. PubMed ID: 1785340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of ubiquitin to experimentally induced murine AA amyloid.
    Chronopoulos S; Alizadeh-Khiavi K; Normand J; Ali-Khan Z
    J Pathol; 1991 Mar; 163(3):199-203. PubMed ID: 1707449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pregnancy and amyloidogenesis: I. Offspring of amyloidotic mice are not predisposed to develop amyloidosis.
    Shtrasburg S; Pras M; Brezniak N; Dolitzki M; Livneh A
    J Lab Clin Med; 1999 Aug; 134(2):168-72. PubMed ID: 10444031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amyloid-enhancing factor: production and response in amyloidosis-susceptible and -resistant mouse strains.
    Gervais F; Hébert L; Skamene E
    J Leukoc Biol; 1988 Apr; 43(4):311-6. PubMed ID: 3162509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterogeneous profiles of a factor that renders neutrophils cytotoxic obtained from a concanavalin A-stimulated spleen cell culture in partial purification process.
    Fujii Y; Inoue T; Ito M; Kimura S; Fuyama S; Arai S; Naiki M; Sendo F
    J Immunol; 1986 May; 136(10):3693-9. PubMed ID: 3701059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunocytochemical evidence of amyloid-enhancing factor (AEF) in polymorphonuclear leukocytes.
    Yokota T; Ishihara T; Kawano H; Takahashi M; Yamashita Y; Gondo T; Fujinaga Y; Uchino F
    Acta Pathol Jpn; 1989 Jun; 39(6):349-55. PubMed ID: 2609961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro analysis of allogeneic lymphocyte interaction. VIII. Characterization of helper components of allogeneic effect factor (AEF) that activate Lyb5+ and Lyb5- B cells to respond to thymus-dependent and thymus-independent antigens.
    Delovitch TL; Kaufman K; Gorczynski RD; Sinclair GD
    J Immunol; 1983 Nov; 131(5):2246-53. PubMed ID: 6605380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term effects of amyloid enhancing factor: clinical and experimental implications.
    Shtrasburg S; Pras M; Brezniak N; Livneh A
    Clin Exp Rheumatol; 1998; 16(3):299-302. PubMed ID: 9631753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo analysis of murine serum sulfate metabolism and splenic glycosaminoglycan biosynthesis during acute inflammation and amyloidosis.
    Lyon AW; Anastassiades T; Kisilevsky R
    J Rheumatol; 1993 Jul; 20(7):1108-13. PubMed ID: 8371201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of murine AA amyloidosis by various homogeneous amyloid fibrils and amyloid-like synthetic peptides.
    Liu Y; Cui D; Hoshii Y; Kawano H; Une Y; Gondo T; Ishihara T
    Scand J Immunol; 2007 Nov; 66(5):495-500. PubMed ID: 17953525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amyloid enhancing factor and dietary transmission in accelerated amyloid A amyloidosis.
    Elliott-Bryant R; Cathcart ES
    Clin Immunol Immunopathol; 1998 Jul; 88(1):65-9. PubMed ID: 9683551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum amyloid A gene expression and AA amyloid formation in A/J and SJL/J mice.
    Rokita H; Shirahama T; Cohen AS; Sipe JD
    Br J Exp Pathol; 1989 Jun; 70(3):327-35. PubMed ID: 2765389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A study on the mechanism of activation of peritoneal exudate macrophages from MRL/MpJ-lpr/lpr mice].
    Hashimoto Y
    Hokkaido Igaku Zasshi; 1988 Sep; 63(5):781-90. PubMed ID: 2853694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The induction of accelerated murine amyloid with human splenic extract. Probable role of amyloid enhancing factor.
    Varga J; Flinn MS; Shirahama T; Rodgers OG; Cohen AS
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 51(3):177-85. PubMed ID: 2874651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostaglandin E1 inhibition of experimental amyloidosis in CBA/J mice.
    Brandwein SR; Sipe JD; Skinner M; Cohen AS
    J Rheumatol; 1985 Jun; 12(3):418-26. PubMed ID: 4045840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential control of IFN-gamma and IL-2 production during Trypanosoma cruzi infection.
    Nabors GS; Tarleton RL
    J Immunol; 1991 May; 146(10):3591-8. PubMed ID: 1902857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.